DDInter4 DDInter832
Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market.
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Abarelix {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metronidazole
Abarelix {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Aripiprazole
Abarelix {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Vasopressin
Abarelix {u} may lead to a major life threatening interaction when taken with {v} Iloperidone
Abarelix may cause a minor interaction that can limit clinical effects when taken with Metronidazole
Abarelix may cause a moderate interaction that could exacerbate diseases when taken with Aripiprazole
Abarelix may cause a moderate interaction that could exacerbate diseases when taken with Vasopressin
Abarelix may lead to a major life threatening interaction when taken with Iloperidone